Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Toragen Logo
Toragen Growth Score
61
CB Rank
47932
Heat Score
58
Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Founded
obfuscation
PrivateGrant San Diego, California, United States11-50 toragen.com
Biotechnology
Overview

Toragen
Total Funding
obfuscation
Growth Score
61
Heat Score
58

Total Funding
obfuscation
Grant raised
obfuscation
Growth Score61
-15 pts
in past quarter
Heat Score 58
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Toragen

CB Rank
47932
Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Founded
obfuscation
PrivateGrant San Diego, California, United States11-50 toragen.com
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Toragen, Inc.
Operating Status Active
Company Type For Profit
Founders  Andrew Sharabi
About the Company
Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Predictions & Insights

Growth Insight

See this Growth Insight
Toragen is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

TGN-S11
A small molecule compound repurposed from an approved antimicrobial drug to inhibit the E5 oncogene protein in HPV-induced cancers.
TGN-S15
A second-generation small molecule compound designed to improve efficacy and reduce side effects compared to TGN-S11 for treating HPV-related cancers.

Research & Development

Toragen is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant
obfuscation
Grant - Toragen Logo
Grant - Toragen
1
obfuscation
Bill & Melinda Gates FoundationGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Bill & Melinda Gates Foundation Logo
Bill & Melinda Gates Foundation
Yes
Grant - Toragen Logo
Grant - Toragen
—
Bill & Melinda Gates Foundation Logo
Bill & Melinda Gates Foundation
Yes
Grant - Toragen Logo
Grant - Toragen
—
Bill & Melinda Gates Foundation Logo
Bill & Melinda Gates Foundation
Yes
Grant - Toragen Logo
Grant - Toragen
—
Bill & Melinda Gates Foundation Logo
Bill & Melinda Gates Foundation
Yes
Grant - Toragen Logo
Grant - Toragen
—
Bill & Melinda Gates Foundation Logo
Bill & Melinda Gates Foundation
Yes
Grant - Toragen Logo
Grant - Toragen
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Board Members and Advisors 4

Employee Profiles

Board Members and Advisors

News

News and Press

News•Oct 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

204
121.67%
 in past month

IT Spend

$49.7KThis year, Toragen is projected to spend $49.7K on IT, according to Aberdeen.

Active Website Tech Count

3Toragen is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Toragen's headquarters? Toragen is located in San Diego, California, United States.Who invested in Toragen? Toragen has 5 investors including Bill & Melinda Gates Foundation and  Scott Rasgon.When was the last funding round for Toragen? Toragen closed its last funding round on
obfuscation
from a Grant round.Who are Toragen's competitors? Alternatives and possible competitors to Toragen may include IO Biotech, Agenus, and  Transgene.How much funding has Toragen raised to date? Toragen has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|